Listed by the USPTO as CHANDRAKUMAR, NIZAL S
Tech Center 1600 • Art Units: 1625 1674
This examiner grants 73% of resolved cases
CHANDRAKUMAR, NIZAL S has 1788 resolved cases, with a 72.7% allowance rate and a median of 834 days to allowance. The profile is assigned to Tech Center 1600 and art unit 1625. The 18.2% interview lift supplies a positive measured association across a substantial resolved-case record.
The listed companies are Revolution Medicines Inc., Beone Medicines I GmbH, and Nicoventures Trading Limited. BakerHostetler, Clark+Elbing LLP - Revolution Medicines, Inc., and FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER are the leading listed firms. The company and firm concentration provides practical reference points for pharmaceutical prosecution planning.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17836814 | ORAL PRODUCTS WITH REDUCED IRRITATION | Final Rejection | NICOVENTURES TRADING LIMITED |
| 18859007 | LIPIDS, FORMULATIONS, AND USES THEREOF | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18705232 | PESTICIDALLY ACTIVE PYRIDAZINONE COMPOUNDS | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 17760181 | Agent For Treating Or Preventing Pancreatic Fistula | Non-Final OA | NOF CORPORATION |
| 18569361 | ROS-RESPONSIVE CAPTOPRIL-CINNAMALDEHYDE PRODRUGS AND COMPOSITIONS AND METHODS THEREOF | Non-Final OA | The University of Hong Kong |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy72.7% of resolved applications examined by Nizal S Chandrakumar were allowed (1,788 resolved cases), compared with 51.6% across Art Unit 1625 over the last five years.
This examiner's interview lift is +18.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Nizal S Chandrakumar took 834 days on average from filing to allowance.
Nizal S Chandrakumar examines applications in Art Unit 1625 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
